Samuel Randazzo and Civil Aviation Safety Authority

Link copied
Case Copied 16 min read

[2014] AATA 581 

Division GENERAL ADMINISTRATIVE DIVISION

File Number

2013/5794

Re

Samuel Randazzo

APPLICANT

And

Civil Aviation Safety Authority

RESPONDENT

DECISION

Tribunal

Mr R Bartsch, Member and Dr W Isles, Member

Date 21 August 2014
Place Sydney

The decision under review is affirmed

.......................[sgd].................................................

Mr R Bartsch, Member and Dr W Isles, Member

CATCHWORDS

CIVIL AVIATION - Conditions placed upon pilots licence - Condition imposed requiring pilot to undertake all flights with safety pilot present - Applicant with medical conditions - Atrial fibrillation - Whether applicant likely to endanger the safety of air navigation - History of compliance with medications unsatisfactory - Conditions appropriately imposed - Decision under review affirmed

LEGISLATION

Civil Aviation Act 1988 (Cth), ss 9A, 20AB(1)

Civil Aviation Regulations 1988 (Cth), regs 5.04, 11.056

Civil Aviation Safety Regulations 1998 (Cth) (CASR), regs 67.150, 67.155, 67.180, 67.195

CASES

Civil Aviation Safety Authority v Ovens [2011] FCAFC 75

Randazzo and Civil Aviation Safety Authority [2011] AATA 375
Randazzo and Civil Aviation Safety Authority [2012] AATA 266
Re Hall and Civil Aviation Safety Authority [2004] AATA 21

Re Window and Civil Aviation Authority [1999] AATA 525

REASONS FOR DECISION

Mr R Bartsch, Member and Dr W Isles, Member

21 August 2014

INTRODUCTION

  1. The applicant, Mr Samuel Randazzo, has applied to this Tribunal for review of a decision of the respondent, the Civil Aviation and Safety Authority (CASA), made on 16 October 2013 (the reviewable decision) which placed a number of conditions on his medical certificate, including a requirement to fly at all times with a safety pilot. Mr Randazzo’s review application is directed towards the imposition of the safety pilot condition, He is not appealing any of the other conditions imposed on his medical certificate.

  2. Mr Randazzo, who turned 77 years of age the day following the hearing, has held a private pilot licence since 1963. He has a number of medical conditions which are not in dispute. Mr Randazzo finds the conditions relating to the carriage of a safety pilot onerous, and does not believe that the condition is necessary to meet the interests of air safety. Mr Randazzo considers this to be the case given his good state of health and the fact that in May 2013 he underwent a cardiac procedure, pulmonary vein isolation (PVI), which lowered his risk of developing atrial fibrillation.

    PREVIOUS TRIBUNAL APPLICATIONS

  3. Mr Randazzo has applied to this Tribunal previously for review of similar decisions made by CASA to impose conditions on his medical certificate. Mr Randazzo was successful when he first appealed the imposition of the safety pilot conditions by CASA in this Tribunal in June 2011.[1] He and his representative, Mr English, asked the Tribunal to only consider the two medical conditions which were of prime concern at that time, atrial fibrillation and Gastro Intestinal Stromal Tumour (GIST). They stated that the GIST was no longer of any concern, and that the risk of atrial fibrillation has been greatly reduced by the PVI procedure. The respondent agreed that those…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Samuel Randazzo and Civil Aviation Safety Authority and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2014] AATA 581
Decision Date

CaseChat Overview and Summary

Samuel Randazzo sought to have the Civil Aviation Safety Authority's (CASA) conditions on his pilot's licence reviewed. The conditions required him to undertake all flights with a safety pilot present due to his medical conditions, specifically atrial fibrillation. The dispute was heard by the Administrative Appeals Tribunal (AAT). The Tribunal needed to determine whether Mr. Randazzo's medical conditions, particularly his atrial fibrillation, posed a significant risk to air navigation safety, and if the conditions imposed by CASA were appropriate. The Tribunal also had to consider Mr. Randazzo's history of compliance with medications and his proposed alternative conditions.

The Tribunal examined the evidence provided by Mr. Randazzo and CASA's principal medical officer, Associate Professor Pooshan Navathe. The evidence highlighted the risks of incapacitation during bouts of atrial fibrillation, the risk of stroke, and the complications associated with anticoagulant medication. The Tribunal found that the risks of incapacitation and stroke were real and not insignificant, particularly given Mr. Randazzo's other risk factors for stroke. The Tribunal was concerned with Mr. Randazzo's unsatisfactory history of compliance with medications and his evasion of taking warfarin, as recommended by CASA. The Tribunal noted that although Mr. Randazzo proposed limiting his flying hours, the potential consequences of inflight incapacitation were such that the risk would still be unacceptable if he flew without a safety pilot.

The Tribunal affirmed the decision under review, maintaining the safety pilot conditions on Mr. Randazzo's class 2 medical certificate. The Tribunal concluded that the risks of incapacitation and stroke were real and significant, and that Mr. Randazzo's history of compliance with medications did not instil confidence in his future compliance. The Tribunal rejected Mr. Randazzo's proposal to limit his flying hours, finding it incongruent to impose safety pilot conditions based on the risk but then allow him to fly without them based on reduced flying time.

ORDERS:
The Tribunal affirmed the decision under review. The suite of conditions referred to as "Safety Pilot Conditions" should remain on Mr. Randazzo's class 2 medical certificate.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Both parties have agreed that the atrial fibrillation (AF) is the prime risk factor to be considered in this hearing. Before examining the extent to which that may persist, we will consider what risks the AF poses for flight safety. CASA's concerns are a risk of incapacitation of the pilot during a bout of AF, as well as the risk of stroke. Additionally there are risks associated with taking anti coagulant medication to prevent stroke. The need for medication also introduces issues of side effects and compliance. MEDICAL EVIDENCE Mr Randazzo and Associate Professor Pooshan Navathe, principal medical officer with CASA, gave oral testimony in person before the Tribunal, while Dr Eggleston, Mr Randazzo's treating cardiologist, gave his evidence by telephone.Risk of incapacitation from atrial fibrillation Mr Randazzo has suffered from paroxysmal atrial fibrillation (AF) for some 15 years. Prior to his PVI procedure, Dr Eggleston reported in 2010 that he was suffering bouts of AF approximately every 6 months. His symptoms during those bouts were described as mild with feelings of fatigue, palpitations and a reduction in exercise tolerance.[5] In evidence Mr Randazzo only admitted to some shortness of breath on exercise and pointed out that he could still play golf and drive a car. Associate Professor Navathe told the Tribunal that such symptoms could well be magnified if they were to occur at altitude while flying a plane and was concerned that they could be incapacitating. [5] T Documents report of Dr. Eggleston dated 3rd February 2010.The risk of stroke There is no argument that AF carries a risk of stroke. It is also common ground that a stroke at any time, but particularly while flying, could be catastrophic and incapacitating. Associate Professor Navathe explained that when the heart is in AF it decreases the ability of the heart to pump blood and this can lead to some stagnation of blood in the atrium. That blood can then form clots which can travel to the brain causing stokes. The fact that most patients are treated with anticoagulants, which carry their own risks of complications, demonstrates that the medical experts believe the risk of stoke is significant. Anticoagulation treatment Associate Professor Navathe said that the risk of stroke in AF is 3 to 4%, but treatment with anti coagulants reduces this to 1%. Importantly, as the Associate Professor notes, the risk is not entirely eliminated. We were told that there are two classes of anticoagulants. The first is warfarin which has been an established treatment for many years and is preferred by CASA. The other is a group of newer medications called NOAGs (novel oral anticoagulants). These are not approved by CASA for use by pilots for reasons discussed below. There was some confusion about just what anticoagulants Mr Randazzo has been taking. Dr Eggleton in his latest report of February 2014 noted that Mr Randazzo was on rivaroxaban, one of the NOAGs, but noted that he thought he had previously been taking warfarin. When questioned on this issue, Mr Randazzo stated that he had never taken Warfarin and had been taking rivaroxaban for the past two years. This seems to be at odds with two reports from the Heart Rhythm Centre dated 19 July[6] and 22 November 2013.[7] The first reported that he was taking warfarin and the second "cartia" a low dose aspirin. Ms Swain also referred the Tribunal to an email from Mr Randazzo to CASA dated 2 July in which he says he has ceased Rivaroxaban and was taking cartia, and that he had asked for a prescription for warfarin which he would start taking if the AF were to reoccur. [6] Exhibit G. [7] Exhibit H.

Decision

Reasons for decision

We therefore do not accept the reasoning behind such a proposal, because having decided that there is a risk sufficient to warrant the imposition of the safety pilot conditions, it be incongruent for the Tribunal to then allow the applicant to exercise the privileges of his licence without those conditions no matter how many hours Mr Randazzo might spend in the cockpit. DECISION The Tribunal affirms the decision under review. The suite of conditions listed above at paragraph 14, and referred to as "Safety Pilot Conditions", should remain on Mr Randazzo's class 2 medical certificate.

Ratio Decidendi

Legal Principle Established

Associate Professor Navathe pointed out that that the risk of stroke was higher in Mr Randazzo’s case because of the presence of other risk factors. He referred to a paper which used a stroke risk score called CHAD-VASC. This score takes into account the other risk factors for conditions such as hypertension, age and diabetes.[10] He said Mr Randazzo's risk score was in the higher range which therefore further added to his risk. [10] Exhibit J.CONSIDERATION We accept that Mr Randazzo feels well and feels that he is in good health. It is clear that he enjoys flying, is a competent pilot and that a condition requiring a safety pilot on his flights is seen as an imposition by him. We see that the risks of incapacitation in the cockpit from either the AF itself or from stroke are real and not insignificant. The risks of stroke are higher for Mr Randazzo because of the presence of other risk factors. We are also satisfied that the PVI procedure, while decreasing the risk of AF, has not reduced the risk sufficiently to justify a removal of the conditions imposed by CASA. The most telling point is that Mr Randazzo's own treating cardiologist, in compliance with the current clinical guidelines, recommended that he should continue taking anticoagulants. We know that anticoagulants carry risks which are significant and would not be prescribed unless there was a real and substantial need. Ironically, although the anticoagulants reduce the risk of stroke they also carry their own, albeit lower, risks of bleeding. Mr Randazzo's evasion and resistance to taking warfarin as advised by CASA does not instil this Tribunal with confidence when considering the likelihood of future compliance – a factor which we accept is very important. Mr Randazzo wrote to the Tribunal after the hearing stating that he was prepared to take Warfarin if it meant he could hold a Class 2 licence without the safety pilot conditions. We note the risks inherent with both classes of anticoagulants. While we understand CASA's preference for the use of warfarin, our final decision is not influenced by which type of anticoagulant Mr Randazzo is presently taking. The applicant asserted that because he only flew approximately 50 hours per year, his risk of inflight incapacitation was thus lower and such a factor should be considered by the Tribunal. He offered to have a further condition added to his licence, which would restrict the number of hours he was permitted to fly within any year. Although the likelihood of such an inflight incapacitation would be reduced by virtue of the reduced flying time the potential consequences should such an event occur are such that the risk would still be of an unacceptable level if Mr Randazzo was the sole pilot onboard the aircraft. We therefore do not accept the reasoning behind such a proposal, because having decided that there is a risk sufficient to warrant the imposition of the safety pilot conditions, it be incongruent for the Tribunal to then allow the applicant to exercise the privileges of his licence without those conditions no matter how many hours Mr Randazzo might spend in the cockpit. DECISION